- Home
- LEG vs CLDX Comparison
LEG vs CLDX Comparison
Compare LEG & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEG
- CLDX
- Stock Information
- Founded
- LEG 1883
- CLDX 1983
- Country
- LEG United States
- CLDX United States
- Employees
- LEG N/A
- CLDX N/A
- Industry
- LEG Home Furnishings
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LEG Consumer Discretionary
- CLDX Health Care
- Exchange
- LEG Nasdaq
- CLDX Nasdaq
- Market Cap
- LEG 1.7B
- CLDX 1.8B
- IPO Year
- LEG N/A
- CLDX 2008
- Fundamental
- Price
- LEG $9.69
- CLDX $25.14
- Analyst Decision
- LEG Hold
- CLDX Buy
- Analyst Count
- LEG 3
- CLDX 7
- Target Price
- LEG $12.67
- CLDX $64.83
- AVG Volume (30 Days)
- LEG 2.2M
- CLDX 1.1M
- Earning Date
- LEG 02-06-2025
- CLDX 11-06-2024
- Dividend Yield
- LEG 2.06%
- CLDX N/A
- EPS Growth
- LEG N/A
- CLDX N/A
- EPS
- LEG N/A
- CLDX N/A
- Revenue
- LEG $4,442,300,000.00
- CLDX $9,976,000.00
- Revenue This Year
- LEG N/A
- CLDX N/A
- Revenue Next Year
- LEG N/A
- CLDX N/A
- P/E Ratio
- LEG N/A
- CLDX N/A
- Revenue Growth
- LEG N/A
- CLDX 128.55
- 52 Week Low
- LEG $9.64
- CLDX $22.93
- 52 Week High
- LEG $26.91
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- LEG 23.35
- CLDX 42.64
- Support Level
- LEG $9.64
- CLDX $23.94
- Resistance Level
- LEG $12.29
- CLDX $26.66
- Average True Range (ATR)
- LEG 0.50
- CLDX 1.36
- MACD
- LEG -0.24
- CLDX -0.07
- Stochastic Oscillator
- LEG 1.62
- CLDX 25.48
About LEG Leggett & Platt Incorporated
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.